Antihistamine • Nasal Decongestant
Purchase Stahist AD or AHIST tablets, and if after taking 6 tablets you don't feel adequate relief from your allergy symptoms, simply return the 24 pills, within 30 days of purchase for a full refund.
• LOW cost + HIGH effectiveness = GREAT VALUE!
• Do you suffer from runny nose, sneezing, itching of the nose or throat, itchy, watery eyes, nasal congestion or swollen nasal passages? Stahist AD or AHIST can relieve your symptoms!
• Don't miss out on this opportunity! If you are not fully satisfied with the product after 6 doses, return the remaining 24 tablets for a FULL REFUND!
Product must by returned with the original receipt and through a carrier with package tracking (e.g., UPS, Fed Ex or USPS registered mail) to:
10801 Electron Drive, Suite 100
Louisville, KY 40299
Not available online. Does not require a prescription. For availability check with your local Pharmacy or Pharmacist.
• Unique Formula: chlorcyclizine HCl 25 mg (antihistamine, NOT chlorpheniramine), pseudoephedrine HCl 60 mg (decongestant).
• The antihistamine chlorcyclizine HCl has a prolonged action and a lower incidence of drowsiness (Hardman, Limbird, & Gillman, 2006).
• Better anticholinergic control of rhinorrhea [and postnasal drip] among first-generation antihistamines (Wallace & Dykewicz, 2008).
• Lower dosage of pseudoephedrine (60 mg per tablet, up to 180 mg perday).
• Dosage can be titrated up to three times per day (up to one tablet every 8 hours, maximum three tablets per day) according to individual patient needs; also scored tablet.
• Low cost, great value!
Active Ingredients (in each immediate-release tablet) Chlorcyclizine HCI 25 mg Antihistamine Pseudoephedrine HCI 60 mg Nasal Decongestant
Temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies: •runny nose •sneezing •itching of the nose or throat •itchy, watery eyes •nasal congestion •reduces swelling of nasal passages
Do not exceed recommended dosage.
Do not use this product • If you are taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for two weeks after stopping the MAOI drug. If you do not know if your prescription drug contains MAOI, ask a doctor or pharmacist before taking this product.
Ask a doctor before use if you have • a breathing problem such as emphysema or chronic bronchitis • glaucoma • heart disease • high blood pressure • thyroid disease • diabetes melitus • difficulty in urination due to enlargement of the prostate gland. Ask a doctor before use if you are taking sedatives or tranquilizers
When using this product • excitability may occur, especially in children • may cause drowsiness • alcohol, sedatives and tranquilizers may increase drowsiness effect • avoid alcoholic beverages • use caution when driving a motor vehicle or operating machinery. Stop use and ask a doctor if • nervousness, dizziness or sleeplessness occur • symptoms do not improve within 7 days or are accompanied by fever • new symptoms occur. If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of accidental overdose, seek professional help or contact a Poison Control Center immediately.
Do not exceed recommended dosage. Adults and children 12 years of age and over:1 tablet by mouth every 6-8 hours, not to exceed 3 tablets in 24 hours, or as directed by a doctor. Children 6 to under 12 years of age: ½ tablet by mouth every 6-8 hours, not to exceed 1½ tablets in 24 hours, or as directed by a doctor. Children under 6 years of age: Consult a doctor
Magnesium Stearate, Microcrystalline Cellulose, Sodium, Starch Glycolate
Questions or Comments?
MAGNA Pharmaceuticals, Inc. • 10801 Electron Drive, Suite 100
Louisville, KY 40299 • www.magnaweb.com
Hardman, J., Limbird, L. & Gilman, A. (2006). Muscarinic receptor antagonists. The Pharmacological Basis of Therapeutics, 11th Edition, 188-189
Wallace, D. & Dykewicz, M. (2008). The diagnosis and management of rhinitis: an updated practice parameter. Journal of Allergy and Clinical Immunology, 122:S1-8